Evaluation of the VEGA Knee System® Range of Motion

November 12, 2018 updated by: Aesculap Implant Systems

Prospective, Long-Term, Multi-Center Study on the Efficacy of the VEGA System® for Total Knee Arthroplasty.

The primary objective of this study is to evaluate the function of the knee after a total knee replacement with the VEGA system®.

Study Overview

Detailed Description

To evaluate patients after total knee arthroplasty in terms of function for five years.

Study Type

Observational

Enrollment (Actual)

7

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Colorado
      • Denver, Colorado, United States, 80220
        • Rose Medical Center
    • Florida
      • Vero Beach, Florida, United States, 32960
        • DBA Hussamy Sports and Hand Center
    • North Carolina
      • Asheville, North Carolina, United States, 28801
        • Charles J DePaolo, MD, PA

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients who have undergone a total knee arthroplasty with the VEGA knee system®

Description

Inclusion Criteria:

  • willing to sign the informed consent.
  • Patient has intact collateral ligaments.

Exclusion Criteria:

  • Inflammatory arthritis
  • Patients that have had a high tibial osteotomy or femoral osteotomy
  • Patients with neuromuscular or neurosensory deficiency which would make it difficult to assess the device performance.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
WOMAC
Time Frame: Two years
WOMAC function score 2 years post arthroplasty
Two years

Secondary Outcome Measures

Outcome Measure
Time Frame
Health related quality of life
Time Frame: Two years
Two years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Khaled Saleh, Southern Illinois University School of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2013

Primary Completion (Actual)

July 1, 2015

Study Completion (Actual)

July 1, 2015

Study Registration Dates

First Submitted

January 14, 2013

First Submitted That Met QC Criteria

January 15, 2013

First Posted (Estimate)

January 16, 2013

Study Record Updates

Last Update Posted (Actual)

November 14, 2018

Last Update Submitted That Met QC Criteria

November 12, 2018

Last Verified

November 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • AAG-O-H-1105

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patients With Total Knee Arthroplasty Using the VEGA System

Subscribe